The United States population is aging faster than ever, attracting interest in longevity stocks. By 2030, one in five Americans will be a senior citizen, up from one in twenty 100 years ago.
The world anti-aging market was worth about $62 billion in 2021, and by 2027, it’s projected to be worth about $93 billion.
As the number of individuals more than 60 rises to 2.1 billion by 2025, longevity stocks will fare well as biotechnology advances like artificial intelligence-driven drug discovery provide fast-acting anti-aging drugs, which means it’s the right time to look at three longevity stocks with over 50% upside.
This post appeared first on InvestorPlace.